Murray, Nigel P.Fuentealba, CynthiaReyes, EduardoSalazar, Anibal2021-12-172021-12-172021-07Hematology, Transfusion and Cell Therapy, Vol. 43, N° 3, July–September (2021) p. 353-3562531-1379http://hdl.handle.net/20.500.12254/2141Renal infarction is an infrequent condition resulting from obstruction of a renal artery. The symptoms it causes are non-specific and as a result the diagnosis may be missed, resulting in loss of renal parenchyma, or the risk of other thrombotic phenomenon. The estimated incidence of renal infarction, based on emergency service admissions, is between 0.004 and 0.007%.1 Four risk groups for renal infarction have been suggested: renal infarction of cardiac origin, the most common of which is atrial fibrillation; renal infarction associated with renal artery injury; renal infarction associated with thrombophilia, and; finally, idiopathic. The SARS-CoV-2 infection (Covid-19) has been associated with an increased risk of both arterial and venous thrombosis. A meta-analysis reported an incidence of venous thrombosis in 22.7% of Intensive care unit (ICU) patients and 7.9% in non-ICU patients2 and reports of an increased risk of arterial thrombosis in severely ill patients, even in those patients receiving antithrombotic prophylaxis with low molecular weight heparin.3,4 Arterial thrombosis has involved the cerebral, coronary, the aorta and peripheral arteries.3,4 In a report on 241 patients with severe COVID-19, 5.7% suffered from acute ischaemic cerebrovascular disease.3 However, there is limited evidence of the risk of both arterial and venous thrombosis in patients with asymptomatic COVID-19. In this context of asymptomatic patients, we present the case of a previously healthy 25-year-old man with no known risk factors for thrombosis who presented to the emergency services with severe loin pain and had a positive polymerase chain reaction (PCR) test for SARS-CoV-2 infection. The angio-computed tomography (CT) of the abdomen and pelvis showed images consistent with thrombosis in one of the two left renal arteries, associated with renal infarction. We present the clinical and laboratory findings, along with the patient's management.enAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)Renal infacrtionCovid-19Artículohttp://orcid.org/0000-0001-8154-8550https://doi.org/10.1016/j.htct.2021.03.008